{"schema_version":"secwatch.filing_event.v1","accession":"0001773751-22-000226","form_type":"8-K","ticker":"HIMS","cik":"0001773751","company_name":"Hims & Hers Health, Inc.","filed_at":"2022-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.067431+00:00","generated_at":"2026-06-22T05:41:09.795962+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Hims & Hers Q3 revenue $144.8M (+95% YoY); raises FY 2022 guidance; expects Q4 Adj. EBITDA profitability","bullets":["Revenue of $144.8M, up 95% YoY; net loss $(18.8)M vs $(15.9)M a year ago.","Adjusted EBITDA improved to $(6.1)M from $(9.8)M; expects Q4 2022 Adjusted EBITDA profitability.","Subscriptions reached 991,000 (+80% YoY); Q3 net new subscriptions all-time high >170,000.","Raises FY 2022 revenue guidance to $519-522M; Adjusted EBITDA guidance to $(20)-$(18)M.","Gross margin expanded to 79% from 74% YoY; net loss improved on adjusted basis."],"urls":{"canonical":"https://secwatch.observer/filing/0001773751-22-000226","json":"https://secwatch.observer/filing/0001773751-22-000226.json","markdown":"https://secwatch.observer/filing/0001773751-22-000226.md","text":"https://secwatch.observer/filing/0001773751-22-000226.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1773751/000177375122000226/0001773751-22-000226-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1773751/000177375122000226/hims-20221107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T05:41:09.795962+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6cfe8983b85363f561f445e1d12066a4129ee4e7","claim":"Hims & Hers Health, Inc. reported third quarter ended September 30, 2022 results: revenue Revenue was $144.8 million for the third quarter 2022 compared to $74.2 million for the third quarter 2021, net income Net loss was $(18.8) million for the third quarter 2022 compared to $(15.9) million for the third quarter 2021. Guidance raised.","evidence_excerpt":"Hims & Hers Health, Inc. Reports Third Quarter 2022 Financial Results and Raises Full Year 2022 Outlook; Platform Demand and Financial Outperformance Driving Expected Adjusted EBITDA Profitability Beginning in Q4 2022 Quarterly revenue of $144.8 million in Q3 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1773751/000177375122000226/0001773751-22-000226-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Revenue","value":"Revenue was $144.8 million for the third quarter 2022 compared to $74.2 million for the third quarter 2021"},{"label":"Net income","value":"Net loss was $(18.8) million for the third quarter 2022 compared to $(15.9) million for the third quarter 2021"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}